BioStem Technologies, Inc. (BSEM)
OTCMKTS · Delayed Price · Currency is USD
3.800
-0.040 (-1.04%)
At close: Dec 30, 2025
BioStem Technologies Market Cap
BioStem Technologies has a market cap or net worth of $64.41 million as of December 30, 2025. Its market cap has decreased by -74.42% in one year.
Market Cap
64.41M
Enterprise Value
40.64M
Revenue
292.21M
Ranking
n/a
PE Ratio
4.50
Stock Price
$3.80
Market Cap Chart
Since August 4, 2009, BioStem Technologies's market cap has increased from 4.77M to 64.41M, an increase of 1,249.07%. That is a compound annual growth rate of 17.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 29, 2025 | 64.41M | -72.05% |
| Dec 31, 2024 | 230.43M | 143.12% |
| Dec 29, 2023 | 94.78M | 160.66% |
| Dec 30, 2022 | 36.36M | 267.00% |
| Dec 30, 2021 | 9.91M | -25.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 764.81M |
| Glass House Brands | 704.73M |
| Elite Pharmaceuticals | 521.06M |
| American Oncology Network | 394.40M |
| Northwest Biotherapeutics | 352.68M |
| CytoDyn | 342.85M |
| Silence Therapeutics | 292.85M |
| Nika Pharmaceuticals | 291.10M |